Drug class
Antiemetic
Antiemetics are a diverse therapeutic class of medications used to prevent or relieve nausea and vomiting. Read more about Antiemetic
531 drugs in this class 193 manufacturers
Drugs in Antiemetic
MECLIZINE HCL
PROCHLORPERAZINE MALEATE
PROCHLORPERAZINE MALEATE
ONDANSETRON HCL
ONDANSETRON HCL
ONDANSETRON HCL
ONDANSETRON HCL
ONDANSETRON HCL
Antiemetics are a diverse therapeutic class of medications used to prevent or relieve nausea and vomiting.
They exert their therapeutic effects primarily by disrupting emetic signaling pathways centrally in the chemoreceptor trigger zone and solitary tract nucleus, or peripherally in the gastrointestinal tract, through the blockade of specific neurotransmitter receptors such as serotonin 5-HT3, neurokinin-1, dopamine D2, histamine H1, or muscarinic acetylcholine receptors.
Clinically, these agents are widely utilized across oncology for chemotherapy- and radiation-induced emesis, perioperative medicine for postoperative nausea and vomiting, gastroenterology, and neurology for motion sickness and vertigo-related disorders.
-
fda.gov
Antiemetics are a diverse therapeutic class of medications used to prevent or relieve nausea and vomiting
-
cancer.gov
Antiemetics are a diverse therapeutic class of medications used to prevent or relieve nausea and vomiting
-
fda.gov
They exert their therapeutic effects primarily by disrupting emetic signaling pathways centrally in the chemoreceptor trigger zone and solitary tract nucleus, or peripherally in the gastrointestinal tract, through the blockade of specific neurotransmitter receptors such as serotonin 5-HT3, neurokinin-1, dopamine D2, histamine H1, or muscarinic acetylcholine receptors Clinically, these agents are widely utilized across oncology for chemotherapy- and radiation-induced emesis, perioperative medicin...
-
nih.gov
They exert their therapeutic effects primarily by disrupting emetic signaling pathways centrally in the chemoreceptor trigger zone and solitary tract nucleus, or peripherally in the gastrointestinal tract, through the blockade of specific neurotransmitter receptors such as serotonin 5-HT3, neurokinin-1, dopamine D2, histamine H1, or muscarinic acetylcholine receptors
-
nih.gov
They exert their therapeutic effects primarily by disrupting emetic signaling pathways centrally in the chemoreceptor trigger zone and solitary tract nucleus, or peripherally in the gastrointestinal tract, through the blockade of specific neurotransmitter receptors such as serotonin 5-HT3, neurokinin-1, dopamine D2, histamine H1, or muscarinic acetylcholine receptors
-
nih.gov
Clinically, these agents are widely utilized across oncology for chemotherapy- and radiation-induced emesis, perioperative medicine for postoperative nausea and vomiting, gastroenterology, and neurology for motion sickness and vertigo-related disorders
-
nih.gov
Clinically, these agents are widely utilized across oncology for chemotherapy- and radiation-induced emesis, perioperative medicine for postoperative nausea and vomiting, gastroenterology, and neurology for motion sickness and vertigo-related disorders
-
nih.gov
Clinically, these agents are widely utilized across oncology for chemotherapy- and radiation-induced emesis, perioperative medicine for postoperative nausea and vomiting, gastroenterology, and neurology for motion sickness and vertigo-related disorders
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.